Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIBECA
NCT07276802Phase 4Not yet recruiting
- Sponsor
- Research Insight
- Start
- Apr 2026
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone acetonide, clobetasol in postoperative pain, post-operative inflammation, sponsored by Research Insight. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
triamcinolone acetonideclobetasol
03
Conditions
postoperative painpost-operative inflammation
Beyond the preview
Go deeper on NCT07276802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07276802.